Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as a unknown/unknown for intravenous use. It treats hemophilia A in patients requiring factor VIII replacement. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate is a recombinant recombinant recombinant factor VIII product that acts on the intrinsic pathway of the blood clot cascade for hemophilia A. - Hemophilia A (severe and moderate severity levels ): Provides temporary correction of factor VIII deficiency to prevent bleeding episodes. -  C    t   t  t  t ---  --- --- --- --- --- --- --- --- --- --- --- --- Ind  g ---  g --- ---. ---